BioNTech SE Alternatives & Competitors
12 companies similar to BioNTech SE — Our vision is to harness the power of the immune system to develop novel therapi...
Companies similar to BioNTech SE
Moderna
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
Cambridge, United States
Crossbow Therapeutics, Inc
Established antibody engineering to target the untapped universe of intracellular cancer t...
Cambridge, United States
NextPoint Therapeutics, Inc.
Launching a new world of precision therapeutics through its leading scientific work on th...
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Hayward, United States
Rival Readout
Competing with BioNTech SE? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
iOmx Therapeutics AG
Developing next-generation targeted cancer immunotherapy treatments
Germany
Singapore, Singapore
Xencor
Proteins by Design
Pasadena, United States
Orum Therapeutics
A public biotechnology company pioneering a novel class of protein degraders.
Lexington, United States
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
San Diego, United States
About BioNTech SE
BioNTech SE, founded in 2008 and headquartered in Germany, is a distinguished player in the Health Care industry, aiming to leverage the immune system for novel therapies against cancer and infectious diseases. With a workforce of approximately 6,100, BioNTech is notable for its extensive computational discovery and dr...
Development of immunotherapies, mRNA vaccine development, Oncology treatment advancement, Research & Innovation
Cancer patients, Medical professionals, Healthcare institutions, Research collaborators
Immunotherapy, MRNA Therapeutics, Oncology, Individualized Cancer Medicine, Patient-specific Immunotherapy, CAR T Cells, Bispecific Antibodies, Antibody-drug Conjugates, Small Molecule Immunomodulators, Infectious Diseases, Cell Therapy, Protein-based Therapeutics, Chimeric Antigen Receptor
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BioNTech SE: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BioNTech SE on 19 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
